0001209191-20-010481.txt : 20200219
0001209191-20-010481.hdr.sgml : 20200219
20200219160431
ACCESSION NUMBER: 0001209191-20-010481
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200214
FILED AS OF DATE: 20200219
DATE AS OF CHANGE: 20200219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassella James V
CENTRAL INDEX KEY: 0001353528
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36310
FILM NUMBER: 20629636
MAIL ADDRESS:
STREET 1: 2091 STIERLIN COURT
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONCERT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001367920
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-860-0045
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: SUITE 3000N
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: CONCERT PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060628
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-14
0
0001367920
CONCERT PHARMACEUTICALS, INC.
CNCE
0001353528
Cassella James V
C/O CONCERT PHARMACEUTICALS, INC.
65 HAYDEN AVENUE, SUITE 3000N
LEXINGTON
MA
02421
0
1
0
0
Chief Development Officer
Common Stock
2020-02-14
4
A
0
28216
A
80481
D
Stock Option (Right to Buy)
10.87
2020-02-14
4
A
0
42430
0.00
A
2030-02-13
Common Stock
42430
42430
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Common Stock of the Issuer.
The RSUs granted to Mr. Cassella will vest in three equal annual installments measured from the date of grant. The number above represents the maximum number of shares that may be delivered pursuant to the award.
Not applicable.
The shares underlying this option vest in equal quarterly installments over a four-year period measured from the date of grant.
/s/ Nancy Stuart as Attorney-in-Fact for James V. Cassella
2020-02-19